[Hybrid Seminar held on April 4th] The theme is hyperhidrosis! Target search and work style reform in your spare time with KIBIT Amanogawa
How do I decide on keywords?
Even if you have decided on the name of the disease, have you ever had trouble choosing keywords to find appropriate information?
・Setting keywords in PubMed takes time and requires a certain amount of time
・I want to try a keyword with a different angle than usual, but I can't think of anything and put it off
・I want to investigate disease-related genes, but I don't have the time.
The paper search AI system "KIBIT Amanogawa" can solve these problems!
In this seminar, we will use the example of "target discovery for hyperhidrosis" to introduce how to use KIBIT Amanogawa to eliminate the hassle of keyword searches and make effective use of spare time between experiments and work.
[Date and time] Thursday, November 2025, 4 17:11~40:12
* Demo experience session (real-life venue only): Thursday, July 2025, 4 17:12-30:13 (free to leave)
[Format] Online (Zoom Webinars) & real venue held simultaneously
*Bento and drinks will be provided at the real venue.Please join us as a luncheon seminar.
[Venue] FRONTEO Co., Ltd. Shinagawa Head Office 4th floor AI Tech Lounge
(Address: Meisan Takahama Building, 108-0075-2 Konan, Minato-ku, Tokyo 12-23)
*Capacity: 10 people (first-come, first-served basis. If the capacity is exceeded, you will be placed on a waiting list for cancellations)
[Participation conditions]
We kindly ask that you refrain from applying if you are using the free address, if you are in the same industry as us, or if you do not know your affiliation.When accessing Zoom on the day, please enter your name and email address that you entered at the time of application in the entry field for Zoom participation.
FRONTEO Inc.
Life Science AI Business Headquarters
AI drug discovery team manager
Go Nakazono
Majored in applied physics at Fukuoka University Faculty of Science.
Worked as a key account manager in BtoB business in the advertising industry.
In the pharmaceutical industry, he has experience in MR, marketing, academics, etc., mainly targeting rare diseases, blood diseases, and pediatric diseases. His previous job was as an area manager at Takeda Pharmaceutical Company.
Currently working on expanding the AI drug discovery business at the Life Science AI Business Headquarters.
FRONTEO Inc.
Manager, Life Science AI Research Team, Life Science AI Business Headquarters
Ph.D. (Pharmacy)
Kazumi Hayashi
After obtaining a doctorate in pharmaceutical sciences, he joined Yamanouchi Pharmaceutical (currently Astellas Pharma).He is active as a research manager in the fields of inflammation, cardiovascular systems, and kidneys.He established the Drug Repurposing Laboratory and engaged in DR research. He is in charge of devising analysis methods using KIBIT, planning analysis policies, analysis, and hypothesis generation.
Articles in the same category
[Hybrid Seminar held on June 6th] Discovery-based paper search AI explores the potential of cancer immunotherapy and exosomes as a biomarker
[Online Seminar Held on May 5th] Learn from Case Studies! Real Troubles in M&A: Five Lessons Legal Departments Should Learn
[Online seminar held on May 5] "Prevention" and "Response in the event of an emergency" regarding the taking of trade secrets by former employees <22rd of XNUMX-part course> Prevention - Confidentiality management and leak prevention -
[Online Seminar held on May 5th] Towards an era of fighting at zero cost: Strategic use of TPF
[Hybrid Seminar held on May 5th] Considering the relationship between menopausal symptoms and lipid profile using paper search AI
[Online Seminar held on April 4] Drug Discovery AI Factory × PLOM-CON analysis accelerates novel target discovery and mechanism elucidation
[Online seminar held on April 4th] "Preventive measures" and "emergency response" for cases of former employees taking trade secrets <24nd of XNUMX-part course> Emergency response Emergency response - Civil measures and internal disciplinary measures -
[Online Seminar Held on April 4th] Former JFTC Investigator on the Current State of the Leniency Program - The Role of Digital Forensics and Effective Practical Solutions
[Online Seminar held on April 4] Economic security regulations to be aware of when doing business in China
